Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LM2221 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y012864 | IM / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8361AA | IM / RA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 1 | 3CA22C1 | IM / LA |
Patient left office with only sore arms which is typical for post injection administration. No other adverse reactions were noted. Patient was administered COVID Pfizer for the age group of 12+ instead of 5-11 years. Grandmother accompanied patient to her wellness exam on 1/31/2025. Consent was obtained from mother via phone while in office. Dose does not need to be repeated. System accepted the dose for COVID for the season.
N/A
N/A
None
N/A
N/A